TLR4 Cancer Research Results
TLR4, Toll-like receptor 4: Click to Expand ⟱
| Source: |
| Type: |
Also called CD284 (cluster of differentiation 284)
A key activator of the innate immune response and plays a central role in the fight against bacterial infections.
Accumulating evidences demonstrated that the activation of TLR4 in tumor microenvironment can not only boost the anti-tumor immunity but also give rise to immune surveillance and tumor progression. "double-edged sword” role of TLR4 activation
|
Park, Parkinson's Disease (PD): Click to Expand ⟱
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms, and is due to the degeneration of dopaminergic neurons. It is multifactorial, caused by genetic and environmental factors and currently has no definitive cure.
-CoQ10 deficiency was observed at a higher frequency in Parkinson's disease
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*neuroP↑, *antiOx↑, *ROS↓, *Inflam↓, *TNF-α↓, *IL1β↓, *PI3K↑, *Akt↑, *BBB↑, *NRF2↑, *SOD↑, *GPx↑, *MAPK↓, *Catalase↑, *HO-1↑, *COX2↓, *PGE2↓, *PPARγ↑, *TLR4↓, *GSK‐3β↓, *Aβ↓, *NLRP3↓, *BDNF↑, *TrkB↑, *GABA↑, *AChE↓, *Ach↑, *5HT↑, *cognitive↑, *MAOA↓,
| - |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*neuroP↑, *antiOx↑, *Inflam↓, *BioAv↝, *BioAv↑, *Half-Life↝, *TLR4↓, *NF-kB↓, *iNOS↓, *COX2↓, *TNF-α↓, *12LOX↓, *NLRP3↓, *ROS↓, *IL1β↓, *IL6↓, *GSK‐3β↓, *NRF2↑, *BBB↑, *SOD↑, *GPx↑, *MDA↓,
| - |
in-vivo, |
IBD, |
NA |
|
|
|
- |
in-vivo, |
Park, |
NA |
|
|
|
*GutMicro↑, Risk↓, *Inflam↓, *antiOx↓, *ZO-1↑, *iNOS↓, *IL6↓, *NO↓, *PGE2↓, *memory↑, *TLR4↓, *NF-kB↓, *IBI↑, *CLDN3↑, *CLDN1↑, *MUC1↑, *OCLN↑, *iNOS↑, *COX2↓, *IFN-γ↓, IL1β↓, ADAM10?,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*Inflam↓, *antiOx↑, *AChE↓, *BBB↑, *cardioP↑, *neuroP↑, *memory↑, *TAC↑, *ROS↓, *lipid-P↓, *MDA↓, *SOD↑, *Catalase↑, *NRF2↑, *cognitive↑, *IL1β↓, *COX2↓, *TNF-α↓, *TLR4↓, *BDNF↑, *PKCδ↑, *5LO↓, *TRPM7↓, *GSH↑, *other↑, *Ferroptosis↓, *GPx4↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*neuroP↑, *Inflam↓, *antiOx↑, *cardioP↑, *NRF2↑, *AMPK↑, *SOD↑, *Catalase↑, *GSH↑, *GPx↑, *ROS↓, *TNF-α↓, *IL6↓, *NF-kB↓, *COX2↓, *glucose↓, *TRPC1↓, *Ca+2↓, *HO-1↑, *NF-kB↓, *PPARα↝, *Hif1a↓, *JNK↓, *BP↓, *AntiDiabetic↑, *hepatoP↑, *TLR4↓, *NRF2↑, *Casp↓, *neuroP↑, *Aβ↓, *LDH↓, *MDA↓, *memory↑, *AChE↓, *eff↑, EMT↝, N-cadherin↓, E-cadherin↑, TumCCA↑, ROS↑, p‑P53↑, HO-1↑, NRF2↑, ChemoSen↑, mtDam↑, Casp3↑, Casp9↑, PARP↑, Bax:Bcl2↑, TumCG↓, cycD1/CCND1↓, cMyc↓, CDK2↓, mitResp↓, Glycolysis↓, Hif1a↓, PCNA↓, p‑GSK‐3β↓, VEGF↓, PI3K↓, Akt↓, mTOR↓, OS↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*antiOx↑, *NRF2↑, *HO-1↑, *Inflam↓, *neuroP↑, *cardioP↑, *other↓, *ROS↓, *NADPH↓, *Catalase↑, *GPx1↑, *NO↓, *mt-ROS↓, *SIRT3↑, *SIRT1↑, *TLR4↓, *mTOR↓, *cognitive↑, *Sepsis↓, *PTEN↓, *Akt↓, *NLRP3↓, *AntiAg↑, *IL6↓, *TNF-α↓, *IL1β↓, *MDA↓, *memory↑, *FOXO3↑, TumCG↓, *LDL↓,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*Inflam↓, *antiOx↑, *neuroP↑, *IL6↓, *IL1β↓, *NF-kB↓, *PGE2↓, *COX2↓, *MMP↑, *memory↑, *ROS↓, *Aβ↓, *HMGB1↓, TumCG↓, MARK4↓, Zeb1↓, MDM2↓, BNIP3↑, ASC↑, NLRP3↓, PI3K↓, Akt↓, Casp1↓, E-cadherin↑, STAT3↓, TLR4↓, MMP↓, ICAM-1↓, AMPK↓, IL6↑, MMP2↓, Warburg↓, Bcl-xL↓, Bcl-2↓, TumCCA↑, EMT↓, TumMeta↓, mTOR↓, HSP27↓, Casp3↑, GlucoseCon↓, lactateProd↓, VEGF↓, p‑p65↓, GIT1↓, FOXM1↓, cycD1/CCND1↓, CDK4↓, MMP9↓, HDAC2↓,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*neuroP↑, *ROS↓, *Inflam↓, *Apoptosis↓, *BBB?, *tau↓, *NF-kB↓, *IL1β↓, *TNF-α↓, *IL4↓, *MAPK↓, *memory↑, *cognitive↑, *Aβ↓, *ROS↓, *lipid-P↓, *GSH↑, *MDA↓, *SOD↑, *Catalase↑, *AChE↓, *BChE↓, *p‑ERK↓, *p‑JNK↓, *p‑p38↓, *GutMicro↑, *COX2↓, *iNOS↓, *TLR4↓, *neuroP↑, *Strength↑, *AMPK↑, *MMP↑, *necrosis↓, *NRF2↑, *HO-1↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*hepatoP↑, *neuroP↑, *TLR4↓, *TNF-α↓, *IL1β↓, *NF-kB↓, *memory↑, *cognitive↑, *NRF2↑, *HO-1↑, *ROS↓, *Akt↑, *mTOR↑, *SOD↑, *Catalase↑, *GSH↑, *IL10↑, *IL6↑, *NO↓, *MDA↓, *AChE↓, *MAPK↓, *BDNF↑,
Showing Research Papers: 1 to 9 of 9
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 9
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
HO-1↑, 1, NRF2↑, 1, ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
mitResp↓, 1, MMP↓, 1, mtDam↑, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↓, 1, cMyc↓, 1, GlucoseCon↓, 1, Glycolysis↓, 1, lactateProd↓, 1, Warburg↓, 1,
Cell Death ⓘ
Akt↓, 2, Bax:Bcl2↑, 1, Bcl-2↓, 1, Bcl-xL↓, 1, Casp1↓, 1, Casp3↑, 2, Casp9↑, 1, MDM2↓, 1,
Protein Folding & ER Stress ⓘ
HSP27↓, 1,
Autophagy & Lysosomes ⓘ
BNIP3↑, 1,
DNA Damage & Repair ⓘ
p‑P53↑, 1, PARP↑, 1, PCNA↓, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, CDK4↓, 1, cycD1/CCND1↓, 2, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, EMT↝, 1, FOXM1↓, 1, p‑GSK‐3β↓, 1, HDAC2↓, 1, mTOR↓, 2, PI3K↓, 2, STAT3↓, 1, TumCG↓, 3,
Migration ⓘ
E-cadherin↑, 2, GIT1↓, 1, MARK4↓, 1, MMP2↓, 1, MMP9↓, 1, N-cadherin↓, 1, TumMeta↓, 1, Zeb1↓, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 1, VEGF↓, 2,
Immune & Inflammatory Signaling ⓘ
ASC↑, 1, ICAM-1↓, 1, IL1β↓, 1, IL6↑, 1, p‑p65↓, 1, TLR4↓, 1,
Synaptic & Neurotransmission ⓘ
ADAM10?, 1,
Protein Aggregation ⓘ
NLRP3↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1,
Clinical Biomarkers ⓘ
FOXM1↓, 1, IL6↑, 1,
Functional Outcomes ⓘ
OS↑, 1, Risk↓, 1,
Total Targets: 61
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↓, 1, antiOx↑, 6, Catalase↑, 6, Ferroptosis↓, 1, GPx↑, 3, GPx1↑, 1, GPx4↑, 1, GSH↑, 4, HO-1↑, 5, lipid-P↓, 2, MDA↓, 6, NRF2↑, 8, ROS↓, 9, mt-ROS↓, 1, SIRT3↑, 1, SOD↑, 6, TAC↑, 1,
Mitochondria & Bioenergetics ⓘ
MMP↑, 2,
Core Metabolism/Glycolysis ⓘ
12LOX↓, 1, AMPK↑, 2, glucose↓, 1, LDH↓, 1, LDL↓, 1, NADPH↓, 1, PPARα↝, 1, PPARγ↑, 1, SIRT1↑, 1,
Cell Death ⓘ
Akt↓, 1, Akt↑, 2, Apoptosis↓, 1, Casp↓, 1, Ferroptosis↓, 1, iNOS↓, 3, iNOS↑, 1, JNK↓, 1, p‑JNK↓, 1, MAPK↓, 3, necrosis↓, 1, p‑p38↓, 1,
Transcription & Epigenetics ⓘ
Ach↑, 1, other↓, 1, other↑, 1,
Proliferation, Differentiation & Cell State ⓘ
p‑ERK↓, 1, FOXO3↑, 1, GSK‐3β↓, 2, mTOR↓, 1, mTOR↑, 1, PI3K↑, 1, PTEN↓, 1, TRPM7↓, 1,
Migration ⓘ
5LO↓, 1, AntiAg↑, 1, Ca+2↓, 1, CLDN1↑, 1, MUC1↑, 1, PKCδ↑, 1, TRPC1↓, 1, ZO-1↑, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 1, NO↓, 3,
Barriers & Transport ⓘ
BBB?, 1, BBB↑, 3, CLDN3↑, 1, IBI↑, 1, OCLN↑, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 7, HMGB1↓, 1, IFN-γ↓, 1, IL10↑, 1, IL1β↓, 7, IL4↓, 1, IL6↓, 5, IL6↑, 1, Inflam↓, 8, NF-kB↓, 7, PGE2↓, 3, TLR4↓, 8, TNF-α↓, 7,
Synaptic & Neurotransmission ⓘ
5HT↑, 1, AChE↓, 5, BChE↓, 1, BDNF↑, 3, GABA↑, 1, MAOA↓, 1, tau↓, 1, TrkB↑, 1,
Protein Aggregation ⓘ
Aβ↓, 4, NLRP3↓, 3,
Drug Metabolism & Resistance ⓘ
BioAv↑, 1, BioAv↝, 1, eff↑, 1, Half-Life↝, 1,
Clinical Biomarkers ⓘ
BP↓, 1, GutMicro↑, 2, IL6↓, 5, IL6↑, 1, LDH↓, 1,
Functional Outcomes ⓘ
AntiDiabetic↑, 1, cardioP↑, 3, cognitive↑, 5, hepatoP↑, 2, memory↑, 7, neuroP↑, 10, Strength↑, 1,
Infection & Microbiome ⓘ
Sepsis↓, 1,
Total Targets: 105
Scientific Paper Hit Count for: TLR4, Toll-like receptor 4
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:75 Cells:% prod#:% Target#:559 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page